Skip to content

Penumbra PEN Cumulative Cost Basis

Cumulative Cost Basis at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
Stryker logo
StrykerSYK

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's cumulative cost basis?
Penumbra (PEN) reported cumulative cost basis of $375.37M in Q1 2026.
How has Penumbra's cumulative cost basis changed year-over-year?
Penumbra's cumulative cost basis increased by 13282.2% year-over-year, from $2.81M to $375.37M.
What is the long-term trend for Penumbra's cumulative cost basis?
Over 5 years (2020 to 2025), Penumbra's cumulative cost basis has grown at a 13.0% compound annual growth rate (CAGR), from $194.32M to $357.81M.